MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-13-2025
VolitionRx Limited ROE Ratio 2011-2026 | VNRX
Annual ROE Ratio VolitionRx Limited
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 109.44 | 457.27 | 1188.29 | -152.29 | - | -113.39 | -148.34 | -148.32 | -56.22 | -157.67 | -2230.85 | -545.63 | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1188.29 | -2230.85 | -163.43 |
Quarterly ROE Ratio VolitionRx Limited
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 82.1 | 93.86 | 106.48 | 113.95 | 527.76 | 914.27 | 718.46 | 548.0 | 272.9 | -416.0 | -442.11 | -536.04 | -569.95 | -328.76 | -160.14 | -74.5 | -101.11 | -93.81 | -103.83 | -93.52 | -122.97 | -125.8 | -124.13 | -88.33 | -125.2 | -132.63 | -141.18 | -113.02 | -152.11 | -154.33 | -151.28 | -107.52 | -123.95 | -101.29 | -80.44 | -42.13 | -91.15 | -123.73 | -140.75 | -113.22 | -1714.06 | -3265.88 | -3013.08 | -1975.01 | -2110.99 | -646.13 | -1021.87 | -423.24 | -735.75 | -912.29 | -870.11 | -520.38 | -675.67 | -518.44 | -465.51 | -244.85 | -155.29 | -58.79 | -30.78 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 914.27 | -3265.88 | -360.26 |
ROE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Anixa Biosciences
ANIX
|
-72.07 | $ 2.89 | -2.36 % | $ 93.8 K |  USA |
 |
Centogene N.V.
CNTG
|
-170.35 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Agilent Technologies
A
|
22.45 | $ 118.67 | 0.46 % | $ 36.1 B | USA |
 |
Celcuity
CELC
|
-96.68 | $ 109.39 | 1.0 % | $ 4.32 B | USA |
|
Akumin
AKU
|
325.23 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Castle Biosciences
CSTL
|
4.0 | $ 27.81 | -0.64 % | $ 772 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-0.85 | - | - | $ 562 M |  Britain |
 |
Charles River Laboratories International
CRL
|
-4.56 | $ 177.9 | -0.41 % | $ 8.82 B | USA |
 |
Aspira Women's Health
AWH
|
-403.65 | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
65.62 | - | -61.36 % | $ 2.46 M | USA |
 |
Global Cord Blood Corporation
CO
|
10.27 | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
-38.13 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-43.4 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-181.33 | - | 0.12 % | $ 80.1 M | China |
 |
Fulgent Genetics
FLGT
|
-3.77 | $ 14.03 | -1.23 % | $ 424 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
13.32 | - | - | $ 10.7 B | USA |
|
Biodesix
BDSX
|
-205.65 | $ 15.96 | 1.3 % | $ 2.07 B | USA |
 |
Biocept
BIOC
|
-362.16 | - | -13.05 % | $ 7.29 M | USA |
 |
BioNano Genomics
BNGO
|
-316.66 | $ 1.1 | -3.49 % | $ 1.4 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
13.84 | $ 208.55 | -0.82 % | $ 23.1 B | USA |
 |
Danaher Corporation
DHR
|
6.88 | $ 202.93 | -1.44 % | $ 145 B | USA |
 |
Exact Sciences Corporation
EXAS
|
-8.66 | $ 103.39 | 0.04 % | $ 19.5 B | USA |
 |
Bioventus
BVS
|
-90.0 | $ 8.85 | 0.91 % | $ 554 M | USA |
 |
DarioHealth Corp.
DRIO
|
-102.21 | $ 10.5 | -2.33 % | $ 298 M |  Israel |
 |
DexCom
DXCM
|
30.46 | $ 72.97 | -1.1 % | $ 28.5 B | USA |
 |
QIAGEN N.V.
QGEN
|
2.34 | - | - | $ 10.6 B |  Niderland |
 |
Burning Rock Biotech Limited
BNR
|
-43.17 | $ 24.2 | -3.82 % | $ 254 M | China |
 |
CareDx, Inc
CDNA
|
-7.05 | $ 18.66 | -0.45 % | $ 994 M | USA |
 |
Chembio Diagnostics
CEMI
|
-130.86 | - | 0.22 % | $ 16.8 M | USA |
 |
ICON Public Limited Company
ICLR
|
8.31 | $ 108.73 | 0.42 % | $ 8.97 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
65.99 | $ 635.4 | -0.2 % | $ 51.1 B | USA |
 |
Illumina
ILMN
|
-51.54 | $ 130.82 | -1.55 % | $ 20.8 B | USA |
 |
Check-Cap Ltd.
CHEK
|
1734.41 | - | - | $ 9.42 M | Israel |
 |
Guardant Health
GH
|
419.18 | $ 93.48 | 1.35 % | $ 11.7 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
10.17 | $ 283.3 | -1.03 % | $ 23.6 B | USA |
 |
IQVIA Holdings
IQV
|
20.91 | $ 174.31 | 0.02 % | $ 30 B | USA |
 |
Lantheus Holdings
LNTH
|
21.43 | $ 78.0 | 2.23 % | $ 5.26 B | USA |
 |
Brainsway Ltd.
BWAY
|
-27.43 | $ 23.0 | -2.91 % | $ 99.4 M | Israel |
 |
Co-Diagnostics
CODX
|
-41.08 | - | - | $ 79.8 M | USA |
 |
Mettler-Toledo International
MTD
|
-3677.41 | $ 1 317.07 | -0.45 % | $ 27.1 B |  Schweiz |
 |
DermTech
DMTK
|
-176.45 | - | -11.32 % | $ 2.94 M | USA |
 |
Myriad Genetics
MYGN
|
-99.43 | $ 5.26 | 4.99 % | $ 487 M | USA |
 |
NeoGenomics
NEO
|
-12.91 | $ 9.5 | - | $ 1.22 B | USA |
 |
Enzo Biochem
ENZ
|
-46.47 | - | -8.98 % | $ 14.8 K | USA |
 |
Natera
NTRA
|
-77.62 | $ 208.69 | 4.26 % | $ 20.5 B | USA |
 |
Pacific Biosciences of California
PACB
|
-10214.54 | $ 1.54 | -4.94 % | $ 462 M | USA |
 |
Neogen Corporation
NEOG
|
-52.72 | $ 11.01 | -1.3 % | $ 2.39 B | USA |
 |
Precipio
PRPO
|
-40.56 | $ 24.5 | -0.73 % | $ 31.8 M | USA |
 |
Heska Corporation
HSKA
|
-4.71 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-400.51 | - | -20.0 % | $ 1.06 M | USA |